NEW YORK (GenomeWeb News) – The Serious Adverse Events Consortium has selected Expression Analysis as the exclusive provider of genotyping services for its first research project, the genomic services firm said yesterday.
 
The first project will focus on liver toxicity using samples provided by DILIGEN and EUDRAGENE, two European clinical research networks. Expression Analysis said that it will use Illumina's Human 1M DNA Analysis BeadChip to perform the genotyping on these samples.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.